Science Explorer Interactive view Map
Company · Cardiff · United Kingdom

Midatech Pharma (United Kingdom)

midatechpharma.comROR OpenAlex
Research works
84
▲ 261% vs 2013–17
Citations
1.2k
14.8 per fractional work
Top-10% rate
13.3%
record average 16.5%
Open access
27%
world 28%

Not ranked overall: Midatech Pharma (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.51× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.37× its world share, 0 worksImmunology and Micro…Neuroscience: 4.09× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.77× its world share, 0 worksPharmacology, Toxico…Engineering: 0.09× its world share, 0 worksEngineeringMaterials Science: 3.71× its world share, 1 worksMaterials SciencePhysics and Astronomy: 2.99× its world share, 0 worksPhysics and AstronomyMedicine: 1.77× its world share, 2 worksMedicineBusiness, Management and Accounting: 0.69× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 3.49× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.5×. Every wedge is a field page.

Who are the top researchers at Midatech Pharma (United Kingdom)?

Ranked on the composite score, Edward D. Zanders lead among researchers whose main affiliation is Midatech Pharma (United Kingdom).

  1. 1 Edward D. Zanders United Kingdom · #1,202,435 worldwide 33 citations · 29 works
All ranked researchers at Midatech Pharma (United Kingdom)

Which keywords describe research at Midatech Pharma (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Pharmaceutical Industry, Clinical Trials, Pharmacokinetics, Medicinal Chemistry, Molecular Docking, Virtual Screening, Capacity Building and Global Collaboration.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Pharmaceutical Industry5▲ 151×2 topics
  2. Clinical Trials5▲ 9.2×6 topics
  3. Pharmacokinetics5▲ 20×2 topics
  4. Inflammation4▲ 2.2×13 topics
  5. Quality of Life4▲ 3.9×9 topics
  6. Epidemiology4▲ 1.26×17 topics
  7. Machine Learning4▲ 2.3×2 topics
  8. Medicinal Chemistry4▲ 13×2 topics
  9. Innovation4▲ 5.2×2 topics
  10. Capacity Building4▲ 62×2 topics
  11. Molecular Docking4▲ 32×1 topic
  12. Virtual Screening4▲ 65×1 topic
  13. Global Collaboration4▲ 107×1 topic
  14. Health Biotechnology4▲ 230×1 topic
  15. Immunotherapy4▲ 6.7×6 topics
  16. Drug Development Costs4▲ 170×1 topic
  17. Generic Drugs4▲ 170×1 topic
  18. Nanoparticles4▲ 3.2×6 topics
  19. Cancer Therapy4▲ 6.5×4 topics
  20. Biomedical Applications3▲ 3.7×5 topics
  21. Monoclonal Antibodies3▲ 22×3 topics
  22. Drug Delivery2▲ 6.2×4 topics
  23. Tumor Targeting2▲ 20×3 topics
  24. Transcriptional Regulation2▲ 10×4 topics
  25. Leadership2▲ 6.9×2 topics
  26. Glioblastoma2▲ 37×1 topic
  27. Glycemic Control2▲ 16×4 topics
  28. Temozolomide2▲ 37×1 topic
  29. Drug Discovery2▲ 5.5×3 topics
  30. Nanocarriers2▲ 49×1 topic
  31. Publication Bias2▲ 41×2 topics
  32. Surface Engineering2▲ 19×1 topic
  33. Biopharmaceuticals2▲ 29×2 topics
  34. Cardiovascular Risk2▲ 5.9×4 topics
  35. Glycosylation2▲ 9.2×3 topics
  36. Immunogenicity2▲ 38×2 topics
  37. Insulin Therapy2▲ 19×3 topics
  38. Cholesterol2▲ 10×4 topics
  39. BET Bromodomains2▲ 88×1 topic
  40. Regenerative Medicine2▲ 8.3×2 topics

Which research topics does Midatech Pharma (United Kingdom) publish most on?

By volume in 2022–2025: Nanoparticle-Based Drug Delivery, Glioma Diagnosis and Treatment, Health Systems, Economic Evaluations, Quality of Life and Lipoproteins and Cardiovascular Health.

Nanoparticle-Based Drug …0Nanoparticle-Based Drug Delivery: 0 fractional worksGlioma Diagnosis and Tre…0Glioma Diagnosis and Treatment: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksLipoproteins and Cardiovascular Health: 0 fractional worksPhotoreceptor and optogenetics research: 0 fractional worksPhotosynthetic Processes and Mechanisms: 0 fractional worksOrigins and Evolution of…0Origins and Evolution of Life: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 0 fractional worksRNA Interference and Gene Delivery: 0 fractional works
BiomaterialsGeneticsEconomics and EconometricsSurgery4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nanoparticle-Based Drug Delivery Biomaterials 0 works
  2. 2 Glioma Diagnosis and Treatment Genetics 0 works
  3. 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  4. 4 Lipoproteins and Cardiovascular Health Surgery 0 works
  5. 5 Photoreceptor and optogenetics research Cellular and Molecular Neuroscience 0 works
  6. 6 Photosynthetic Processes and Mechanisms Molecular Biology 0 works
  7. 7 Origins and Evolution of Life Astronomy and Astrophysics 0 works
  8. 8 Protein Degradation and Inhibitors Molecular Biology 0 works
  9. 9 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  10. 10 RNA Interference and Gene Delivery Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.4%not open72.6%

World: 28% of research is openly available.

with international co-authors20.5%domestic only79.5%

World: 19% is written across borders.

How has Midatech Pharma (United Kingdom)'s research output changed?

Output in 2018–2022 was 261% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cardiff

All research institutions in Cardiff

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.